|
1
|
Trendowski M: Recent advances in the
development of antineoplastic agents derived from natural products.
Drugs. 75:1993–2016. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Joo YE: Natural product-derived drugs for
the treatment of inflammatory bowel diseases. Intest Res.
12:103–109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim SB, Park SJ, Chung SH, Hahn KY, Moon
DC, Hong SP, Cheon JH, Kim T and Kim WH: Vaccination and
complementary and alternative medicine in patients with
inflammatory bowel disease. Intest Res. 12:124–130. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kang NJ, Lee KW, Kim BH, Bode AM, Lee HJ,
Heo YS, Boardman L, Limburg P, Lee HJ and Dong Z: Coffee phenolic
phytochemicals suppress colon cancer metastasis by targeting MEK
and TOPK. Carcinogenesis. 32:921–928. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Svilaas A, Sakhi AK, Andersen LF, Svilaas
T, Ström EC, Jacobs DR Jr, Ose L and Blomhoff R: Intakes of
antioxidants in coffee, wine, and vegetables are correlated with
plasma carotenoids in humans. J Nutr. 134:562–567. 2004.PubMed/NCBI
|
|
6
|
Ludwig IA, Clifford MN, Lean ME, Ashihara
H and Crozier A: Coffee: Biochemistry and potential impact on
health. Food Funct. 5:1695–1717. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bøhn SK, Blomhoff R and Paur I: Coffee and
cancer risk, epidemiological evidence, and molecular mechanisms.
Mol Nutr Food Res. 58:915–930. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang N and Kitts DD: Role of chlorogenic
acids in controlling oxidative and inflammatory stress conditions.
Nutrients. 8:pii: E162015. View Article : Google Scholar
|
|
9
|
Upadhyay R and Rao LJ Mohan: An outlook on
chlorogenic acids-occurrence, chemistry, technology, and biological
activities. Crit Rev Food Sci Nutr. 53:968–984. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weng CJ and Yen GC: Chemopreventive
effects of dietary phytochemicals against cancer invasion and
metastasis: Phenolic acids, monophenol, polyphenol, and their
derivatives. Cancer Treat Rev. 38:76–87. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim YJ, Chang SY and Ko HJ:
Myeloid-derived suppressor cells in inflammatory bowel disease.
Intest Res. 13:105–111. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Strober W, Fuss I and Mannon P: The
fundamental basis of inflammatory bowel disease. J Clin Invest.
117:514–521. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Podolsky DK and Xavier RJ: Unravelling the
pathogenesis of inflammatory bowel disease. Nature. 448:427–434.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee SH: Intestinal permeability regulation
by tight junction: Implication on inflammatory bowel diseases.
Intest Res. 13:11–18. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morris MC, Gilliam EA and Li L: Innate
immune programing by endotoxin and its pathological consequences.
Front Immunol. 5:6802015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han DS: Current status and prospects of
intestinal microbiome studies. Intest Res. 12:178–183. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu Z, Zhang W and Kone BC: Signal
transducers and activators of transcription 3 (STAT3) inhibits
transcription of the inducible nitric oxide synthase gene by
interacting with nuclear factor kappaB. Biochem J. 367:97–105.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okugawa S, Ota Y, Kitazawa T, Nakayama K,
Yanagimoto S, Tsukada K, Kawada M and Kimura S: Janus kinase 2 is
involved in lipopolysaccharide-induced activation of macrophages.
Am J Physiol Cell Physiol. 285:C399–C408. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Villarino AV, Kanno Y, Ferdinand JR and
O'Shea JJ: Mechanisms of Jak/STAT signaling in immunity and
disease. J Immunol. 194:21–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zundler S and Neurath MF: Integrating
immunologic signaling networks: The JAK/STAT pathway in colitis and
colitis-associated cancer. Vaccines (Basel). 4:pii: E52016.
View Article : Google Scholar
|
|
21
|
Coskun M, Salem M, Pedersen J and Nielsen
OH: Involvement of JAK/STAT signaling in the pathogenesis of
inflammatory bowel disease. Pharmacol Res. 76:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Danese S, Grisham M, Hodge J and Telliez
JB: JAK inhibition using tofacitinib for inflammatory bowel disease
treatment: A hub for multiple inflammatory cytokines. Am J Physiol
Gastrointest Liver Physiol. 310:G155–G162. 2016.PubMed/NCBI
|
|
23
|
Vuitton L, Koch S and Peyrin-Biroulet L:
Janus kinase inhibition with tofacitinib: Changing the face of
inflammatory bowel disease treatment. Curr Drug Targets.
14:1385–1391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim SF: The nitric oxide-mediated
regulation of prostaglandin signaling in medicine. Vitam Horm.
96:211–245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Salvemini D, Kim SF and Mollace V:
Reciprocal regulation of the nitric oxide and cyclooxygenase
pathway in pathophysiology: Relevance and clinical implications. Am
J Physiol Regul Integr Comp Physiol. 304:R473–R487. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim SF: The role of nitric oxide in
prostaglandin biology; update. Nitric Oxide. 25:255–264. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gądek-Michalska A, Tadeusz J, Rachwalska P
and Bugajski J: Cytokines, prostaglandins and nitric oxide in the
regulation of stress-response systems. Pharmacol Rep. 65:1655–1662.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Krakauer T: The polyphenol chlorogenic
acid inhibits staphylococcal exotoxin-induced inflammatory
cytokines and chemokines. Immunopharmacol Immunotoxicol.
24:113–119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wei J and Feng J: Signaling pathways
associated with inflammatory bowel disease. Recent Pat Inflamm
Allergy Drug Discov. 4:105–117. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karrasch T and Jobin C: NF-kappaB and the
intestine: Friend or foe? Inflamm Bowel Dis. 14:114–124. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Broom OJ, Widjaya B, Troelsen J, Olsen J
and Nielsen OH: Mitogen activated protein kinases: A role in
inflammatory bowel disease? Clin Exp Immunol. 158:272–280. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hwang SJ, Kim YW, Park Y, Lee HJ and Kim
KW: Anti-inflammatory effects of chlorogenic acid in
lipopolysaccharide-stimulated RAW 264.7 cells. Inflamm Res.
63:81–90. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shan J, Fu J, Zhao Z, Kong X, Huang H, Luo
L and Yin Z: Chlorogenic acid inhibits lipopolysaccharide-induced
cyclooxygenase-2 expression in RAW264.7 cells through suppressing
NF-kappaB and JNK/AP-1 activation. Int Immunopharmacol.
9:1042–1048. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ruan Z, Liu S, Zhou Y, Mi S, Liu G, Wu X,
Yao K, Assaad H, Deng Z, Hou Y, et al: Chlorogenic acid decreases
intestinal permeability and increases expression of intestinal
tight junction proteins in weaned rats challenged with LPS. PLoS
One. 9:e978152014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shin HS, Satsu H, Bae MJ, Zhao Z, Ogiwara
H, Totsuka M and Shimizu M: Anti-inflammatory effect of chlorogenic
acid on the IL-8 production in Caco-2 cells and the dextran
sulphate sodium-induced colitis symptoms in C57BL/6 mice. Food
Chem. 168:167–175. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zatorski H, Sałaga M, Zielińska M,
Piechota-Polańczyk A, Owczarek K, Kordek R, Lewandowska U, Chen C
and Fichna J: Experimental colitis in mice is attenuated by topical
administration of chlorogenic acid. Naunyn Schmiedebergs Arch
Pharmacol. 388:643–651. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shen X, Tian Z, Holtzman MJ and Gao B:
Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling
pathways: IL-1beta selectively inhibits IL-6-activated signal
transducer and activator of transcription factor 1 (STAT1) by a
proteasome-dependent mechanism. Biochem J. 352:913–919. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shi D, Wang Q, Zheng H, Li D, Shen Y, Fu
H, Li T, Mei H, Lu G, Qiu Y, et al: Paeoniflorin suppresses
IL-6/Stat3 pathway via upregulation of Socs3 in dendritic cells in
response to 1-chloro-2,4-dinitrobenze. Int Immunopharmacol.
38:45–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
